Assistant Professor Develops a Rapid Point-of-Care Detection Technology for SARS-Cov-2
Piyush Jain, Ph.D., an assistant professor in the Department of Chemical Engineering and a member of UF Health Cancer Center, and his Ph.D. student Long Nguyen have developed a CRISPR-based, paper-based, rapid detection technology that can detect SARS-CoV-2 cDNA in as little as 5-10 minutes or SARS-CoV-2 RNA in as low as 30-60 minutes without the need of expensive […]
COVID-19 and Food Safety: Fact and Fiction for Food Production
Consumers are being bombarded with tips for what to do with their groceries during the coronavirus crisis. Leave them in the garage for three days? Wash the produce with soapy water? Wipe all packaging down with disinfectant wipes? Listen to the science, say University of Florida Institute of Food and Agricultural Sciences Food Science and Human […]
DiaCarta Gets FDA Emergency Use Authorization for Coronavirus PCR Test
UF Innovate | Sid Martin Biotech alum DiaCarta, a molecular diagnostic firm, has obtained the Emergency Use Authorization from the US Food and Drug Administration for its QuantiVirus PCR diagnostic (Dx) test for the novel coronavirus. The test detects the N, Orf1ab, and E genes of the SARS-CoV-2 virus in nasopharyngeal swabs, oropharyngeal swabs, and […]
The Big Picture: EPI’s Director Speaks About the Covid-19 Pandemic
The Emerging Pathogens Institute was formed in 2006 to bring researchers across disciplines together with the goal of better understanding and anticipating new disease-causing microorganisms that affect people, plants, and animals. Much of its research is focused globally, with an eye toward what might affect the State of Florida. But for the first time, the […]
TAO Connect Opens Mental Health Resources to the Public at No Cost to Assist With the Effects of COVID-19
UF startup and UF Innovate | The Hub graduate TAO Connect, a digital platform designed to make behavioral health therapy more accessible and effective, announced the offering of a free online help session specific to COVID-19, in addition to opening up its entire suite of mindfulness meditation exercises to the public. Both programs are free […]
Full Interview: Algernon Pharmaceuticals Announces Regulatory Submission for COVID-19 Trial in South Korea
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joined Steve Darling from Proactive Vancouver to discuss another development for their repurposed drug Ifenprodil. Moreau provides an update about the clinical study which will consist of 40 patients and will deal with those currently sick with COVID-19. Learn more about Full Interview: […]
SharpSpring Releases First-of-Its-Kind CRM-Integrated Video Calling and Screen Sharing to Address COVID-19
UF startup SharpSpring, Inc., a leading cloud-based marketing and sales automation platform, announced the release of integrated video calls, a free solution for SharpSpring customers, built to help marketing agencies and SMBs connect with leads, contacts, and clients, mimicking an in-person experience. “While Zoom, Slack, Skype, and other services have been amazing for us, SharpSpring […]
UF-Led Ventilator Design Clears First FDA Review
A ventilator envisioned by a University of Florida engineer and built with do-it-yourself parts gained first-step FDA authorization this week, offering hope that it could be in use within weeks at hospitals around the world where COVID-19 patients have overwhelmed supplies of traditional medical equipment. The ventilator, composed of parts readily available for less than […]
Military Drone Maker, Altavian, Is Churning Out N95 Masks for COVID-19 Response
UF startup Altavian, a drone maker that supplies the US military, has shifted some of its production to a new kind of N95-grade mask to be used by medical personnel on the frontlines of America’s latest battle—the COVID-19 emergency response. In fact, the new masks may even exceed the protection of traditional N95 models. The […]
Full Interview: Algernon Pharmaceuticals Updates Phase 2 Human Testing of Ifenprodil for COVID-19
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joins Steve Darling from Proactive Vancouver to provide an update about its initiated phase 2 clinical study of NP-120 for COVID-19 on infected patients in South Korea. Learn more about Full Interview: Algernon Pharmaceuticals Updates Phase 2 Human Testing of Ifenprodil for […]